| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1192916A Chinese medicine for treatment of gout |
| 09/16/1998 | CN1192911A Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc |
| 09/15/1998 | US5808061 Intermediates and processes for preparing benzothiophene compounds |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/11/1998 | WO1998039443A1 Spα: A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 09/11/1998 | WO1998039332A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient |
| 09/11/1998 | WO1998039024A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2282830A1 Sp.alpha.: a scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2280134A1 Selective mmp inhibitors having reduced side-effects |
| 09/09/1998 | EP0862616A1 Reconstituted mineralized cartilage tissue |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192685A Use of alendronate for preventing osteoporosis |
| 09/09/1998 | CN1192373A Traditional Chinese medicinal powder for treating stagnation of vital energy and blood stasis |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804593 For treatment of connective tissue degradation, osteo-, rheumatoid-, and septic arthritis; osteopenias, osteoporosis, corneal ulceration, peridontal disease, gastric ulcers. |
| 09/08/1998 | US5804570 Administering 4-amino-1-hydroxy-butylidene-1,1-bisphosphonate (alendronate) or salt to osteoporotic female |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/08/1998 | US5804210 Administering orally or parenterally animal safe amount of dibasic calcium phosphate or calcium carbonate and conjugated linoleic acid isomers to enhance calcium content of bone in the animal |
| 09/08/1998 | US5804204 Potassium salts for treatment of hypertension |
| 09/06/1998 | CA2199325A1 Cyclic analogs of pth and pthrp |
| 09/03/1998 | WO1998038303A1 Procollagen assembly |
| 09/03/1998 | WO1998038179A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/03/1998 | WO1998038163A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998037884A1 Inclusion complexes in aqueous solution |
| 09/03/1998 | WO1998037877A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | WO1998028423A3 Compositions and methods of use for osteoclast inhibitory factors |
| 09/03/1998 | WO1998024804A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/03/1998 | CA2282656A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2282655A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/1998 | CA2281664A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 09/02/1998 | EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861092A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | CN1192237A 人MP52 Arg蛋白 People MP52 Arg protein |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1191751A Chinese medicine Gutongning and its preparation |
| 09/02/1998 | CN1191741A Plaster for traumatic injury and its preparation |
| 09/02/1998 | CN1191740A Qihe fracture setting plaster with bone retaining liniment |
| 09/01/1998 | US5801014 Growth differentiation factor-5 |
| 08/27/1998 | WO1998037094A2 Secreted proteins and polynucleotides encoding them |
| 08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
| 08/27/1998 | WO1998037077A1 Calcitonin mimetics |
| 08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 08/27/1998 | WO1998036725A1 Method for the rejuvenation of the neck-face skin structure |
| 08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
| 08/27/1998 | CA2281059A1 Secreted proteins and polynucleotides encoding them |
| 08/26/1998 | EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 08/26/1998 | EP0859779A1 Interleukin converting enzyme and apoptosis |
| 08/26/1998 | EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 08/26/1998 | EP0859766A1 Chiral methyl phenyl oxazolidinones |
| 08/26/1998 | EP0859622A1 Extracts of shark cartilage |
| 08/26/1998 | CN1191567A Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/26/1998 | CN1191485A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substd. amino 1, 2, 3-triazoles |
| 08/26/1998 | CN1191138A Process for preparing prescription and medicinal extract of plaster for activating meridians |
| 08/26/1998 | CN1191119A Analgesic plaster and its preparing method |
| 08/26/1998 | CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence |
| 08/25/1998 | US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors |
| 08/25/1998 | US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer |
| 08/25/1998 | US5798225 Process for recombinant production of PTH and PTHrp analogs |
| 08/25/1998 | CA2122479C Risedronate delayed-release compositions |
| 08/25/1998 | CA2006723C Sulfur-containing heterocyclic compounds |
| 08/20/1998 | WO1998035949A1 Bicyclic amino acids |
| 08/20/1998 | WO1998035704A1 Targeted therapeutic delivery of vitamin d compounds |
| 08/20/1998 | WO1998035674A1 Compositions for the inhibition of bone resorption |
| 08/20/1998 | WO1998035653A1 Implantable collagen-containing putty material |
| 08/20/1998 | WO1998014596A3 Disease associated protein tyrosine phosphatases |
| 08/20/1998 | DE19712659C1 Use of Alchemilla vulgaris extract as angiogenesis inhibitor |
| 08/20/1998 | DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids |
| 08/20/1998 | CA2280722A1 Compositions for the inhibition of bone resorption |
| 08/20/1998 | CA2279590A1 Targeted therapeutic delivery of vitamin d compounds |
| 08/19/1998 | EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| 08/19/1998 | EP0858344A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 08/19/1998 | CN1190896A Stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 08/19/1998 | CN1190593A Medicine for the treatment of rheumatism and arthritis |
| 08/19/1998 | CN1190591A Plaster for replenishing vital essence |
| 08/13/1998 | WO1998035056A1 Identification of inhibitors of protein tyrosine kinase 2 |
| 08/13/1998 | WO1998035043A1 Human sdf-5 protein and compositions |
| 08/13/1998 | WO1998034929A1 Il-8 receptor antagonists |
| 08/13/1998 | WO1998034918A1 Arylsulfonyl hydroxamic acid derivatives |
| 08/13/1998 | WO1998034655A1 Matrix-free osteogenic devices, implants and methods of use thereof |
| 08/13/1998 | WO1998034647A1 Arginine silicate inositol complex and use thereof |
| 08/13/1998 | WO1998034617A1 Treatment and prevention of adhesions |
| 08/13/1998 | WO1998034602A2 Mediation of cytokines by melanin |
| 08/13/1998 | WO1998034583A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
| 08/13/1998 | WO1998030693A3 Tumor necrosis factor receptor 5 |
| 08/13/1998 | WO1998022501A3 Secreted proteins and polynucleotides encoding them |
| 08/13/1998 | CA2280181A1 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |